Azevedo Sette and Veirano advise on Oncomed’s BRL 350m raise
Azevedo Sette Advogados and Veirano have advised on two separate but related capital market transactions totalling BRL 350 million for Oncomed, a cancer prevention and treatment network, aimed at expanding its healthcare operations.
The fundraising was structured across two instruments. The first transaction involved the issuance of BRL150 million in commercial notes — short- and medium-term debt securities — subscribed by Banco Santander Brasil and Banco do Brasil.
The second comprised R$200 million in simple, non-convertible debentures issued through Opea Securitizadora, a securitisation vehicle that transforms receivables and future cash flows into tradeable financial securities. The debentures were backed by the commercial notes issued by Oncomed itself, a structure designed to distribute credit risk and attract fixed-income investment funds.
The transactions also involved a comprehensive security package, including both real guarantees over company assets and personal guarantees (fidejussory guarantees), as well as the sharing of collateral with three prior commercial note issuances by the issuer.
Azevedo Sette Advogados represented Oncomed in the legal structuring and negotiation of the issuance agreements and the guarantee package. The firm’s team was led by Luiz Augusto Azevedo Sette (pictured left) and Natália Meirelles Barros, supported by Pedro Henrique de Castro Oliveira and Carolina Alves Dias de Souza.
Veirano Advogados acted for the financial coordinators of the transactions — Banco Santander, UBS BB and JGP Financial Advisory — with a team comprising Ingrid Thomas Hessling (pictured right), Julio Antonio Nunes Queiroz and Isabella Maciel de Guimaraes.